296 related articles for article (PubMed ID: 12720133)
21. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
22. The malignant clone in Waldenstrom's macroglobulinemia.
Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
24. Origin of Waldenstrom's macroglobulinaemia.
García-Sanz R; Jiménez C; Puig N; Paiva B; Gutiérrez NC; Rodríguez-Otero P; Almeida J; San Miguel J; Orfão A; González M; Pérez-Andrés M
Best Pract Res Clin Haematol; 2016 Jun; 29(2):136-147. PubMed ID: 27825459
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia is comparable to flow cytometric techniques.
Howard MT; Hodnefield J; Morice WG
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):96-8. PubMed ID: 21454202
[TBL] [Abstract][Full Text] [Related]
26. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations.
Treon SP; Kelliher A; Keele B; Frankel S; Emmanouilides C; Kimby E; Schlossman R; Mitsiades N; Mitsiades C; Preffer F; Anderson KC
Semin Oncol; 2003 Apr; 30(2):248-52. PubMed ID: 12720146
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
[TBL] [Abstract][Full Text] [Related]
28. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
Al-Katib AM; Mensah-Osman E; Aboukameel A; Mohammad R
Semin Oncol; 2003 Apr; 30(2):313-7. PubMed ID: 12720160
[TBL] [Abstract][Full Text] [Related]
29. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
Yin CC; Lin P; Carney DA; Handy BC; Rassidakis GZ; Admirand JH; Keating MJ; Medeiros LJ
Am J Clin Pathol; 2005 Apr; 123(4):594-602. PubMed ID: 15743747
[TBL] [Abstract][Full Text] [Related]
30. Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases.
Valdez R; Finn WG; Ross CW; Singleton TP; Tworek JA; Schnitzer B
Am J Clin Pathol; 2001 Nov; 116(5):683-90. PubMed ID: 11710684
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
[TBL] [Abstract][Full Text] [Related]
32. Macroglobulinemia and chronic B-cell type lymphocytic leukemia in japan--study of autopsy cases.
Kikuchi M; Mitsui T; Takeshita M; Okamura H
Jpn J Clin Oncol; 1983 Sep; 13(3):607-22. PubMed ID: 6417377
[TBL] [Abstract][Full Text] [Related]
33. Waldenstrom's macroglobulinaemia.
Jayapal V; Thomas M; Mathew S; Augustine J; Santhamma K; Vijayalekshmi N; Rajan GV; Chandrasekhar KP
J Assoc Physicians India; 1990 Jul; 38(7):510-2. PubMed ID: 2127274
[TBL] [Abstract][Full Text] [Related]
34. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
Kyle RA; Ansell SM; Kapoor P
Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
[TBL] [Abstract][Full Text] [Related]
36. Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice.
Ditzel Santos D; Ho AW; Tournilhac O; Hatjiharissi E; Leleu X; Xu L; Tassone P; Neri P; Hunter ZR; Chemaly MA; Branagan AR; Manning RJ; Patterson CJ; Moreau AS; Ciccarelli B; Adamia S; Kriangkum J; Kutok JL; Tai YT; Zhang J; Pilarski LM; Anderson KC; Munshi N; Treon SP
Exp Hematol; 2007 Sep; 35(9):1366-75. PubMed ID: 17761288
[TBL] [Abstract][Full Text] [Related]
37. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
Naderi N; Yang DT
Arch Pathol Lab Med; 2013 Apr; 137(4):580-5. PubMed ID: 23544948
[TBL] [Abstract][Full Text] [Related]
38. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.
Lin P; Bueso-Ramos C; Wilson CS; Mansoor A; Medeiros LJ
Am J Surg Pathol; 2003 Aug; 27(8):1104-13. PubMed ID: 12883242
[TBL] [Abstract][Full Text] [Related]
39. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
40. [Rearrangements of immunoglobulin heavy chain gene in Waldenstr"om's macroglobulinemia].
Matsuda I; Ishiyama T; Hisatake J; Koike M; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1996 Apr; 37(4):275-9. PubMed ID: 8847796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
